Eye examination revealed a best corrected visual acuity of 6/6 right eye and 6/60 left eye. The positive physical findings were confined to the left fundus. A nonpigmented choroidal tumor was present temporally extending into the fovea and approxi-
In 1872 Perls reported the first case of carcinoma metastatic to the choroid.' Since that time well over 400 cases have been reported. 23 The predominant sources of metastatic carcinoma to the choroid have been lung in men and breast in women. 2 There have been at least 7 reported cases of prostatic carcinoma metastatic to the choroid. 24T his report describes a case of prostatic carcinoma metastatic to the choroid in which hormonal therapy caused complete clinical regression of the metastasis and full return of visual function. To our knowledge this response has not been previously reported with a choroidal metastasis from prostatic carcinoma.
Case report
A 54-year-old white male was referred to the Scott and White Clinic for evaluation of decreased vision in his left eye of 4 months' duration. His past medical history consisted of diabetes mellitus for two years treated with 10 units of insulin per day and chronic hypertension treated with a combination of reserpine, hydralazine, and hydrochlorothiazide. Review of systems revealed impotence, sacral pain, and urinary frequency.
Eye examination revealed a best corrected visual acuity of 6/6 right eye and 6/60 left eye. The positive physical findings were confined to the left fundus. A nonpigmented choroidal tumor was present temporally extending into the fovea and approxi- (Fig. 2) . Fluorescein angiography showed widespread hyperfluorescence due to defects of the retinal pigment epithelium but no distinct tumour circulation (Fig. 3A) . Goldmann perimetry demonstrated an absolute visual field defect nasally in the left eye (Fig.  4A) .
General physical examination was unremarkable with the exception of an enlarged, nodular prostate. On laboratory testing an acid phosphatase level of 21 IU/l (normal 0-6) and a prostatic fraction of 13 IU/I (normal 0-6) was noted. Chest x-rays revealed numerous nodular densities compatible with metastatic lesions. Prostatic needle biopsy confirmed grade 3 moderately well differentiated adenocarcinoma of the prostate (Fig. 5) . No lesions were demonstrable on computerised axial tomography of the head. Bone scan revealed abnormal uptake in the axial skeleton, ribs, and entire left orbit (Fig. 6) .
Over a period of a week the patient was treated with palliative cobalt-60 irradiation to painful bony lesions, transurethal resection of the prostate, and bilateral orchidectomy. In addition he was started on diethylstilboesterol 3 mg per day. Within 2 weeks the choroidal tumour had decreased to one-half its original size (Fig. 1B) and vision had improved to 6/15. In 4 weeks visual acuity improved to 6/6, and within 2 months the tumour was not clinically apparent (Fig. IC) (Fig. 4B) and the acid phosphatase level normal. The only evidence of the previous tumour was atrophy of the retinal pigment epithelium, which was prominent on fluorescein angiography (Fig. 3B) . After 12 months of follow-up he is free of any ocular recurrence.
Discussion
Greenwood and Southard reported the first case of prostatic carcinoma metastatic to the choroid in 2 )>h 2 Prostatic carcinoma can metastasise to the choroid by at least 2 routes. In those individuals with metastases in the lungs, as in our case, tumour emboli pass via the pulmonary circulation into the heart and aorta. They subsequently travel up the carotid arteries to the ophthalmic artery and into the ciliary vessels and uveal tract.
If no pulmonary lesions are present, prostatic or vertebral lesions may seed into Batson's plexus. In Fig. 4 26 Since hormonal manipulation is commonly used to treat widespread metastases from prostatic carcinoma, the effect of this form of therapy on choroidal metastases from the prostate should be observed before recommending radiation therapy.
